Gene Therapy Restores the Transcriptional Program of Hematopoietic Stem Cells in Fanconi Anemia

Investigators demonstrated that gene therapy reverts the transcriptional signature of Fanconi anemia hematopoietic stem and progenitor cells (HSPCs), which then resembles the transcriptional program of healthy donor HSPCs.